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by enhanced degradation of the p53 protein (HPV-E6;
We recently reported the identi®cation of a mouse Scheffner et al., 1990; Werness et al., 1990), or by as
cDNA encoding a new p53-associating protein that yet unknown ways, possibly involving altered oligomer-
we called Mdmx because of its structural similarity ization of p53 (adenovirus type 12 large E1B, adenovi-
to Mdm2, a well-known p53-binding protein. Here we rus type 5 E1A; Steegenga et al., 1995, 1996). Impor-
report the isolation of a cDNA encoding the human tantly, HPV and HBV have been implicated in human
homolog of Mdmx. The ORF of the cDNA encodes a cervical carcinoma and liver carcinoma (Srivastava et
protein of 490 amino acids, 90% similar to mouse al., 1992; Ueda et al., 1995), respectively. In addition,
Mdmx. The homology between Mdmx and Mdm2 is some cellular proteins have been found to bind to p53
most prominent in the p53-binding domain and the and in¯uence its properties as a transcription factor.putative metal-binding domains. The Mdmx protein,
First, the Wilms' tumor protein WT1, a transcriptionwhich, based on SDS±PAGE, has a MW of 80 kDa, can
factor itself, is able to modulate p53-regulated tran-bind p53 in vitro. The human MDMX gene is tran-
scription (Maheswaran et al., 1993). Recently, the E2F1scribed in all tissues tested, with high levels in thy-
and DP1 proteins were also shown to interact directlymus. By ¯uorescence in situ hybridization analysis
with p53 and inhibit its transcription-stimulation func-we mapped the mouse mdmx gene to chromosome 1
tion (O'Connor et al., 1995; Martin et al., 1995). Last,(region F±G) and the human MDMX gene to chromo-
p53 was found to complex with the Mdm2 proteinsome 1q32. q 1997 Academic Press
(Barak and Oren, 1992; Momand et al., 1992). The asso-
ciation of Mdm2 with p53 completely abrogates all
INTRODUCTION transcription-regulating properties of p53 (Momand et
al., 1992; Chen et al., 1995). Mdm2 most likely func-
The loss of wild-type p53 in human malignancies re- tions by concealing the transactivation domain of p53
sults in aberrant cell-cycle progression, escape from (Oliner et al., 1993). Most interestingly, overexpression
apoptosis, and enhanced angiogenesis, which all con- of Mdm2 has been found in a variety of tumors, in
tribute to tumor growth. These biological processes are general correlating with the absence of mutations in
most likely controlled by p53 through its transcription- the p53 gene (Oliner et al., 1992; Reifenberger et al.,
regulating function, which, in human tumors, is usu- 1993; Habuchi et al., 1994; Lianes et al., 1994; Corvi
ally altered due to gene mutations (Hollstein et al., et al., 1995). Overexpression of Mdm2 is apparently
1991, 1994), but can also take place via cytoplasmic suf®cient for inhibition of the p53 tumor-suppression
retention (Moll et al., 1992, 1995) and by association function. Thus, inactivation of p53 in human tumors
with other proteins. Tumor antigens of several DNA can be achieved by mutation, cytoplasmic retention, or
tumor viruses have been shown to inactivate the func- overexpression of Mdm2, or by several viral proteins.
tion(s) of p53, by a tight association (SV40-LT, adenovi- We recently reported the identi®cation of a new p53-
rus type 5 large E1B protein, HBV X-antigen; Lane associating protein. The translation product of this
and Crawford, 1979; Linzer and Levine, 1979; Sarnow gene, named mdmx, shows signi®cant homology with
et al., 1982; Zantema et al., 1985; Feitelson et al., 1993), the Mdm2 protein, especially in the p53-binding do-
main and in the putative functional domains, located
1 Present address: Division of Molecular Carcinogenesis, Nether- in the C-terminal part of the protein. We reported that
lands Cancer Institute, 1066 CX Amsterdam, The Netherlands. the murine Mdmx protein binds to p53 in vivo and, like2 To whom correspondence should be addressed. Telephone: (31) 71
Mdm2, inhibits the activation of transcription by p535276136. Fax: (31) 715276284. E-mail: A.G.Jochemsen@biochemistry.
MedFac.LeidenUniv.NL. (Shvarts et al., 1996). Unlike mdm2, which is a p53-
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with labeled in vitro translated p53. Subsequently the beads wereresponsive gene, mdmx transcription appears not to be
washed three times with binding buffer. Immunoprecipitated andregulated in a p53-dependent manner, at least not after
GST±Mdmx-bound proteins were separated on a 9% SDS±polyacryl-UV irradiation. This might suggest that mdmx is not amide gel, prepared for ¯uorography with 22.5% PPO (2,5- dipheny-
a modi®er of p53 after UV irradiation. We now report loxazole) in dimethylsulfoxide, dried, and exposed to Kodak XAR-5
®lm at 0807C.the isolation of a human cDNA of 2216 bp that encodes
Fluorescence in situ hybridization (FISH). FISH was performedthe human Mdmx protein of 490 aa. The mouse and
on mouse cells regenerated from a muscle biopt and on human lym-human Mdmx proteins have 90% identity at the protein
phocytes. Metaphase spreads were prepared via the standard proce-level. We show that the human Mdmx protein binds to
dures. A total of 400 and 150 ng labeled mdmx probe for mouse and
p53 in vitro. By FISH analysis we mapped the mouse human chromosomes, respectively, and 50x mouse Cot I and 50x
mdmx gene to chromosome 1 region F±G and its hu- human Cot I DNA (Gibco, Life Technology) was dissolved in 12 ml of
a hybridization solution (50% v/v deionized formamide, 10% dextranman homolog to chromosome 1q32. We report the iden-
sulfate, 2x SSC, 1% v/v Tween 20, pH 7.0). Prior to hybridization,ti®cation of a new member of the mdm family that
the probe was denatured at 807C for 10 min, chilled on ice, andmight be involved in human carcinogenesis. incubated at 377C for 30 min allowing preannealing. After denatur-
ation of the slides, probe incubations were carried out under an 20
1 20 mm coverslip in a moist chamber for 45 h. ImmunocytochemicalMATERIALS AND METHODS
detection of the hybridizing probe was achieved with FITC-conju-
gated sheep-anti-digoxigenin (Boehringer).
Northern analysis. A human multitissue Northern blot (Clon- For evaluation of the chromosomal spreads a Zeiss epi¯uorescence
tech) was hybridized with 32P-labeled probes according to the manu- microscope equipped with the appropriate ®lter for visualization of DAPI
facturer's manual. and FITC ¯uorescence was used. Digital images were acquired with a
Isolation and sequencing of human MDMX cDNA. A cDNA li- high-performance cooled CCD camera (Photometrics, Tucson) and fur-
brary from the colonic epithelial cell line T84 in a UNI-Zap-XR vector ther processed on a computer with the help of the BDS-Image FISH
(Stratagene) was screened with mouse mdmx cDNA probe according software package (Biological Detection Systems Inc, Rockville, MD).
to the protocol supplied by the manufacturer. pBSK plasmids con-
RESULTStaining the human MDMX cDNA were obtained with R408 helper
phage (Stratagene).
Molecular Cloning of mdmx cDNADouble-stranded DNA was sequenced by a T7 polymerase sequenc-
ing kit and AutoRead Sequencing kit (Pharmacia). The sequence To identify the human MDMX cDNA we screened
reactions were subsequently analyzed manually on polyacrylamide a cDNA library from the colonic tumorigenic cell line
gel and by the ALF (automatic laser ¯uorescence) DNA sequencing
machine (Pharmacia). All the sequence primers were obtained from
Isogene Bio-Science B.V.
Isolation of genomic mdmx DNA clones. To obtain genomic mouse
mdmx sequences, we screened a genomic mouse library derived from
129/OLA mice in EMBL3A phage using the standard procedure
(Sambrook et al., 1989). Subclones were generated by digestion with
SalI and by cloning the fragments into SalI-digested pIC20R vector.
To obtain human MDMX genomic sequences, library N0. 700 (P1
human), ligated into pAd10SacBII (Francis et al., 1994), was
screened with a fragment of approximately 560 bp obtained by RT-
PCR on mRNA isolated from the human tumor cell line G401 (Weis-
mann et al., 1987) with a primer set corresponding to nt 460±478/
1003±1022. The presence of MDMX-speci®c sequences in the geno-
mic clones was established by Southern blot analysis with the use
of speci®c cDNA probes (data not shown).
In vitro associations between Mdmx and p53. To obtain in vitro
translated Mdmx proteins, the full-length coding regions of mouse
and human Mdmx were cloned into pcDNA3 vector (Invitrogen). Hu-
man p53 protein was translated in vitro from the modi®ed pET15b/
p53 vector (Shvarts et al., 1996) and the human cJun protein from
a pBAT vector (Annweiler et al., 1991) containing the human cJun
coding region (pBAT-cJun, a gift from Dr. P. Angel, Karlsruhe, Ger-
many).
In vitro transcription/translation was performed with the use of
the coupled transcription/translation system obtained from Promega
(Madison, WI) in the presence of [35S]methionine. In vitro translated
Mdmx proteins were incubated in the presence or absence of bacteri-
ally produced p53 proteins (Shvarts et al., 1996) for 30 min on ice.
Subsequent immunoprecipitations were performed as described pre-
viously (Steegenga et al., 1995) with a mixture of the monoclonal
antibodies PAb122/PAb421 directed against p53, the polyclonal rab-
bit antiserum pAb100 directed against a peptide of mouse Mdmx,
or the polyclonal rabbit antiserum pAb55 raised against full-length
human Mdmx. FIG. 1. Schematic representation of human MDMX cDNA clones
obtained from a LambdaZap cDNA library from colon carcinoma cellTo obtain GST±human Mdmx fusion protein, the total coding re-
gion of human Mdmx was cloned into vector pRP259, a modi®ed line T84. The XmnI site in the middle of the cDNA has been used
to obtain the human MDMX cDNA containing the complete openpGEX expression vector (Smith and Johnson, 1988). Approximately
1 mg of GST±Mdmx, bound to beads, was tumbled for 4 h at 47C reading frame.
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FIG. 2. Nucleotide and derived amino acid sequence of human MDMX. (A) Nucleotide sequence of MDMX cDNA and predicted protein
sequence The putative AUG codon is underlined and boldface; putative alternative translation start sites are shown in boldface. Conserved
cysteines in the putative zinc-®nger and in the RING ®nger domains together with the core amino acids are given in boldface italics, and
a putative nuclear localization signal is underlined. (B) Sequence alignment of Mdm-like proteins.
T84 (Stratagene) with a mouse mdmx cDNA probe The shortest construct shows a strong homology with
the 5* part of the previously identi®ed mouse mdmx(see Materials and Methods). Two independent phage
clones, which remained positive after three rounds cDNA (Shvarts et al., 1996), including the putative
translation start site. Sequencing of the longest con-of puri®cation, were isolated and puri®ed to homoge-
neity. Sequence analysis showed inserts of1260 and struct revealed that in the 3 * part of the insert a
stretch of 1143 bp shows a strong similarity with the2260 bp (clone 1 and clone 2, respectively, in Fig. 1).
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FIG. 2ÐContinued
3 * part of the mouse mdmx cDNA, including the Sequence alignment of human MDMX with human
MDM2 revealed, analogous to mouse mdmx, a signi®-translation stop codon. Clone 1 and clone 2 showed
a 700-bp identical sequence (Fig. 1). Comparing these cant homology at both the DNA and the protein levels.
Figure 2A shows the cDNA sequence of human MDMXavailable sequences with the mouse mdmx cDNA and
the human MDM2 cDNA sequence suggested that and the putative open reading frame, encoding a pro-
tein of 490 aa. The sequence alignment of the Mdm-these 700 bp are a real overlap, allowing us to gener-
ate a human MDMX cDNA with the use of an unique like proteins is shown in Fig. 2B. All proteins share the
p53-binding site, which is located in their N-terminusXmnI recognition site present in the 700-bp overlap.
RT-PCR analysis on mRNAs from normal human (Chen et al., 1995; Brown et al., 1993; Haines et al.,
1994; Shvarts et al., 1996). The Mdm2 mRNAs containcells and a human tumor cell line with primers from
outside the overlapping region yielded a fragment of additional AUG codons at positions /50 and /62,
which have been shown to be real alternative transla-a length expected from the combined cDNA (data not
shown). The human MDMX cDNA is at the 3 * end, tion start sites in both in vivo and in vitro translation
assays (Barak et al., 1994; Zauberman et al., 1995).approximately 500 bp longer than the thus far identi-
®ed mouse mdmx cDNA because of a longer 3 *-un- These AUGs are also present in the mdmx sequence at
approximately the same positions (/46,/53, and/61).translated region. This 3 * UTR is similar to that of
the human MDM2 cDNA in that it contains an Alu We have no direct evidence that they function as alter-
native starts in the MDMX mRNA, although in vitrorepeat as has been described for the MDM2 cDNA.
This human MDMX cDNA contains an open reading translation yields protein products of the expected size,
but also of a smaller size (see below). It suggests thatframe of 490 amino acids with strong homology to
the mouse Mdmx protein sequence (Fig. 2A). the MDMX mRNA might give rise to different protein
products, as has been described for Mdm2. At the C-At the moment we do not know for sure the exact
nature of the 5* part of the cDNA insert of clone 2. terminus the putative metal-binding domains, residues
306 to 323 and residues 439 to 479 in the human MdmxHowever, we propose this part to be intron sequences,
because comparison with the genomic organization of protein, are highly conserved between the different
Mdm family members. The latter domain has recentlythe mouse mdm2 gene indicates that the junction be-
tween the unknown 5* sequences and the Mdmx-homol- been reported to be structurally related to a zinc-bind-
ing domain called the RING ®nger (Boddy et al., 1994).ogy region is exactly at a splice acceptor site (Jones et
al., 1996; Montes de Oca Luna, 1996). Another explana- All Mdm proteins contain a putative nuclear localiza-
tion signal (Figs. 2A and 2B). However, the nucleartion for the presence of these sequences is not excluded.
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in pancreas and lung (Ladanyi et al., 1993). A 5.5-kb
MDM2 transcript was detected, but we ®nd the MDM2
gene to be almost equally expressed in all tissues on
this blot with only a somewhat higher expression in the
thymus, but certainly not as prominent as the MDMX
transcript.
In Vitro Interaction between Mdmx and p53
We have shown previously that mouse Mdmx can
bind p53 in vivo (Shvarts et al., 1996). To investigate
the in vitro interaction between human and mouse
Mdmx and human p53, we performed two types of ex-
periments. First, we mixed in vitro translated, 35S-la-
beled Mdmx with bacterially produced and puri®ed p53
protein (see Materials and Methods). After this incuba-
tion immunoprecipitations with anti-p53 and anti-
Mdmx antibodies were performed.
The results presented in Figs. 4A and 4B demon-
strate that in the presence of p53 protein signi®cant
amounts of the in vitro translated human and mouse
Mdmx proteins are coimmunoprecipitated with a mix-
ture of the anti-p53 antibodies PAb 122/PAb 421. Fur-
thermore, it seems that only the upper band of mouse
Mdmx, which is probably generated from the ®rst in-
frame AUG, interacts with p53, suggesting that the
protein lacking the N-terminal part does not bind p53.
Although dif®cult to see in Fig. 4, the same seems to
FIG. 3. Expression of MDMX mRNA in human tissues. (A)
be true for the human Mdmx. To verify the in vitroNorthern blot containing poly(A)/-selected mRNA from human tis-
binding association between human Mdmx and p53, asues was probed with human MDMX cDNA. (B) The same blot was
probed with human MDM2 cDNA. (C) Human b-actin cDNA was GST±Mdmx fusion protein was coupled to glutathione
used as control for the amount of mRNA loaded. Positions of molecu- beads and incubated with 35S-labeled, in vitro trans-
lar-weight markers (kb) are indicated. lated human p53 or cJun as a control. As can be seen in
Fig. 4C, the GST±Mdmx protein speci®cally interacts
with human p53 and not with cJun, while GST alonelocalization signal of the Mdm2 protein is found at posi-
binds neither protein.tions 178±183 (RKRHK), in the middle part of the pro-
We conclude from these results that both humantein, whereas in the human Mdmx protein it is found
and mouse Mdmx proteins associate with p53 proteinat positions 442±445 (KRPR) in the C-terminal part.
in vitro and that the binding domain is probably lo-
Expression of MDMX mRNAs in Human Tissues cated in the extreme N-terminal part of the Mdmx
proteins.To determine the expression pattern of human
MDMX mRNA we performed Northern blot analysis on Chromosomal Mapping of the mdmx Genes
a human multi tissue blot. Figure 3A shows that a
10-kb human MDMX transcript is synthesized in all Ampli®cation of the human MDM2 gene has been
observed in a variety of tumors (Oliner et al., 1992;tissues, with the highest amount in the thymus and
a very low expression in colon. An additional shorter Reifenberger et al., 1993; Habuchi et al., 1994; Lianes
et al., 1994; Corvi et al., 1995). Since the MDMX genetranscript of approximately 2.2 kb is detectable in tes-
tis. We do not know the exact nature of the different might be present in amplicons described in human
tumors, we set out to localize the gene. To begin with,mRNAs, but the mRNA expression pattern of the
mouse and the human is rather conserved and will be the mouse mdmx gene was mapped with FISH to
chromosome 1, region F±G (Lyon and Searle, 1989;discussed in more detail later. Furthermore, expression
of human MDMX mRNA was found in all tissues and Figs. 5A and 5B). This region is in synteny with a
region on the long arm of the human chromosome 1.cell lines tested by RT-PCR (data not shown). We com-
pared the expression of human MDMX with that of This possible location of the human MDMX gene was
veri®ed by FISH analysis with the P1 clone con-MDM2 by reprobing the same blot with an MDM2
probe (Fig. 3B). The human MDM2 gene was pre- taining human MDMX sequences. The human
MDMX gene was mapped to human chromosomeviously shown to be expressed in a 5.5-kb transcript,
®rst identi®ed by Oliner et al. (1992) predominantly in 1q32 (Figs. 5C and 5D). This region was recently re-
ported to be ampli®ed in a subset of liposarcomasskeletal muscle and liver, with somewhat lower levels
AID GENO 4775 / 6r3a$$$$61 06-05-97 19:35:49 gnma
IDENTIFICATION OF HUMAN Mdmx 39
FIG. 4. In vitro association between Mdmx and p53. (A, B) Immunoprecipitations on a mixture of in vitro translated, 35S-labeled Mdmx
proteins and bacterially produced p53 with a mouse Mdmx-speci®c polyclonal antibody pAb100 (aMMDMX), a polyclonal antibody recognizing
human Mdmx pAb55 (aHMDMX), or a mixture of PAb 122/421 (ap53); nonimmune mouse antibody (N.I. mouse) was used in control
immunoprecipitations as indicated. (C) GST±HMDMX fusion protein or only GST bound to glutathione beads was mixed with either in
vitro translated 35S-labeled p53 protein or cJun protein. After this incubation the beads were washed and bound proteins were separated
on SDS±PAGE.
(Szymanska et al., 1996; Forus et al., 1995). The pos- quence. We expect the Mdmx amino acid sequence to
sible ampli®cation of the MDMX gene in these tu- be as presented here, since upstream from the putative
mors is currently under investigation. AUG, in-frame stop codons are found. The apparent
molecular weight of human Mdmx is somewhat larger
than that earlier found for mouse Mdmx. This mightDISCUSSION
be caused by different posttranslational modi®cations,
e.g., phosphorylation, which is known to occur on theWe report here the isolation and identi®cation of the
Mdm2 proteins.human counterpart of the mouse mdmx gene. The hu-
A sequence comparison between human MDMX andman MDMX gene encodes a protein of 490 aa that is
human MDM2 reveals conservation that is strongest90% homologous to mouse Mdmx (Shvarts et al., 1996).
in the p53-binding domain located in the N-terminalThe amino acid sequence predicts a protein with a theo-
part of both proteins. Furthermore, putative functionalretical molecular weight of 54 kDa. However, on SDS±
domains in the C-terminal part of the proteins arePAGE human Mdmx was found to migrate as a protein
highly conserved. These domains consist of a zinc ®ngerwith a molecular weight of approximately 80 kDa. This
and a zinc-binding domain called the RING ®nger. Thebehavior corresponds to the observation that the Mdm2
latter is thought to be involved in protein±protein in-protein also runs at a much higher molecular weight
on SDS±PAGE than expected from its amino acid se- teraction (Boddy et al., 1994).
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FIG. 5. Chromosomal localization of the mdmx genes by ¯uorescence in situ hybridization. (A, C) Mapping of the mdmx gene on mouse
and human metaphase chromosomes, respectively. Probe DNA, light spots; chromosomes are counterstained with DAPI. (B, D) Giemsa-
like banding to identify the chromosome and localize the probe on mouse chromosome 1 F±G and on human chromosome 1q32. At least
20 informative chromosome spreads were used to determine the localization of the mdmx genes.
By Northern blot analysis we detect a 10-kb tran- primed mRNAs. Second, an entry in the NCBI EST
database of 275 bp (L44283), derived from human thy-script of human MDMX in most tissues, with a rela-
tively high expression in thymus. Also mouse thymus mus RNA, is identical over a stretch of 113 bp with the
human MDMX cDNA sequence shown here (Fig. 6).was found to express relatively high levels of the mu-
rine mdmx mRNAs (data not shown). The murine From studies on the genomic organization of the mouse
gene we know this to be exon 2. Both 5* and 3 * of thesemdmx gene is expressed prominently into two long
mRNAs of approx. 10 and 7.5 kb in all tested tissues exon sequences the sequence of the EST diverges from
the cDNA sequence (Fig. 6), but now shows similarityand a mRNA of 2.2 kb, which is highly expressed in
testis and to a very low level in other tissues (Shvarts with intron sequences of the mouse mdmx gene (not
shown). These results already suggested that unsplicedet al., 1996). An MDMX mRNA of approx. 2.2 kb is also
found in human testis. This mRNA is not detected in or not fully spliced mdmx mRNAs are expressed. In
addition, we performed an RT-PCR assay on mousethe other tissues, but if the expression of this mRNA
in the other tissues is as low relative to the longer thymus mRNA with one primer derived from exon 2
and another from the following intron. A product ofmRNA as in mouse tissues, it might be a detection
problem. Thus, the mRNA expression patterns of the the expected length could be detected, again suggesting
that (partly) unspliced mdmx mRNAs are expressed.human and mouse mdmx genes are rather similar, with
the possible exception of the shorter mRNAs in tissues The 5* end of cDNA most likely represents the ap-
proximate 5* end of the mRNA, as indicated by 5*-other than testis. It is not ®rmly established whether
the mRNAs detected all contain the coding region here RACE experiments (Shvarts et al., 1996) and because
in the mouse genome just upstream of this region pro-presented. However, we hypothesize that the longer
hybridizing RNA band represents not (fully) processed motor activity was found (R.C.A. van Ham and A.G.
Jochemsen, unpublished results). From these resultsmRNA because of the following reasons. First, the
cDNA clone 2 we isolated most likely contains intron we hypothesize that the long mRNAs represent not
fully processed mRNA and that the cDNA sequence wesequences, while the library was made from oligo(dT)-
FIG. 6. Alignment of the 5*-part of the human MDMX cDNA sequence with an EST from the NCBI database (Accession No. L44283).
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tissues from patients with primary hepatocellular carcinoma. On-now show is a representation of the smaller mRNA of
cogene 8: 1109±1117.2.2 kb, although other possibilities cannot be excluded.
Forus, A., Olde Weghuis, D., Smeets, D., Fodstad, O., Myklebost, O.,Thus, although we ®nd the human MDMX 10-kb
and Geurts van Kessel, A. (1995). Comparative genomic hybridiza-mRNA to be highly expressed in thymus, it remains to tion analysis of human sarcomas. I. Occurrence of genomic imbal-
be seen whether this has consequences at the protein ances and identi®cation of a novel major amplicon at 1q21±q22 in
level. It is not excluded that the unspliced mRNAs also soft tissue sarcomas. Genes Chromosomes Cancer 14: 8±14.
code for Mdmx-like proteins, since in clone 2 an in- Francis, F., Zehetner, G., Hoglund, M., and Lehrach, H. (1994). Con-
struction and analysis of the ICRF human P1 library. Genet. Anal.frame ATG codon is present just eight amino acids in
Tech. Appl. 11: 5±6.front of the Mdmx-homology region. It will be interest-
Habuchi, T., Kinoshita, H., Yamada, H., Kakehi, Y., Ogawa, O., Wu,ing to ®nd out whether this relatively high mRNA ex-
W. J., Takahashi, R., Sugiyama, T., and Yoshida, O. (1994). Onco-pression will turn out to be important in the differentia-
gene ampli®cation in urothelial cancers with p53 gene mutation
tion of T-cells or be re¯ected in a role of MDMX (over)- or MDM2 ampli®cation. J Natl. Cancer Inst. 86: 1331±1335.
expression in hematological malignancies, as has been Haines, D. S., Landers, J. E., Engle, L. J., and George, D. L. (1994).
reported for MDM2 (Bueso-Ramos et al., 1993; Maestro Physical and functional interaction between wild-type p53 and
mdm2 proteins. Mol. Cell. Biol. 14: 1171±1178.et al., 1995; Zhou et al., 1995). MDM2 ampli®cation is
found in approximately 30% of human sarcomas Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. (1991).
p53 mutations in human cancers. Science 253: 49±53.(Oliner et al., 1992). A recent analysis of liposarcomas
Hollstein, M., Rice, K., Greenblatt, M. S., Soussi, T., Fuchs, R., Sorlie,shows 50% ampli®cation in 12q14, most probably in-
T., Hovig, E., Smith-Sorensen, B., Montesano, R., and Harris, C. C.volving MDM2. In several liposarcomas (4/14) ampli®-
(1994). Database of p53 gene somatic mutations in human tumorscation around 1q32 has also been found, possibly indi- and cell lines. Nucleic Acids Res. 22: 3551±3555.
cating involvement of MDMX (Szymanska et al., 1996).
Jones, S. N., Ansarilari, M. A., Hancock, A. R., Jones, W. J., Gibbs,
Whether the MDMX gene is present in this amplicon R. A., Donehower, L. A., and Bradley, A. (1996). Genomic organiza-
is currently under investigation. tion of the mouse double minute 2 gene. Gene 175: 209±213.
Ladanyi, M., Lewis, R., Jhanwar, S. C., Gerald, W., Huvos, A. G.,
and Healey, J. H. (1995). MDM2 and CDK4 gene ampli®cation inACKNOWLEDGMENTS
Ewing's sarcoma. J. Pathol. 175: 211±217.
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